Skip to main content
Fig. 3 | BMC Medical Informatics and Decision Making

Fig. 3

From: A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients

Fig. 3

The comparison between the fourteen-lncRNA-based RFS classifier and clinicopathological features in all MIBC samples. a. Univariate Cox proportional-hazards regression analysis results of fourteen-lncRNA-based classifier and clinicopathological features, respectively. b. ROC curve of low- and high-risk sets verified by the fourteen-lncRNA-based classifier and clinicopathological features, respectively

Back to article page